Brusnitsyn, D. V.
Ramazanova, A. N.
Medyantseva, E. P.
Ramazanova, E. R.
Prytkova, A. V.
Karimova, E. R.
Ziganshin, M. A.
Burilov, V. A.
Makarov, E. G.
Khamidullin, T. L.
Article History
Received: 11 October 2024
Revised: 6 November 2024
Accepted: 6 November 2024
First Online: 6 May 2025
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
: All studies were conducted in accordance with the principles of biomedical ethics set out in the 1964 Helsinki Declaration and its subsequent amendments. They were also approved by the Ethics Committee of the Interregional Clinical Diagnostic Center (Kazan, Russia), protocol no. 134 dated August 15, 2023. Each study participant gave voluntary written informed consent after receiving an explanation of the potential risks and benefits, as well as the nature of the upcoming study.
: The authors of this work declare that they have no conflicts of interest.